Cargando…
Encapsulated papillary carcinoma of the breast: A single institution experience
Encapsulated papillary carcinoma (EPC) is a relatively rare form of breast cancer. To date, no evidence-based guidelines for the treatment of EPC have been established. Between January 2015 and December 2021, patients with histologically confirmed EPC of the breast were recorded in a database by The...
Autores principales: | Xu, Liang, Mao, Qixin, Liu, Qiuming, Gao, Yufeng, Luo, Lihua, Guo, Chungen, Qu, Wei, Yan, Ningning, Cao, Yali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509775/ https://www.ncbi.nlm.nih.gov/pubmed/37736553 http://dx.doi.org/10.3892/ol.2023.14046 |
Ejemplares similares
-
Diagnosis, treatment, and outcomes of encapsulated papillary carcinoma: a single institution experience
por: Steponavičienė, Laura, et al.
Publicado: (2018) -
Encapsulated papillary carcinoma of the breast: An institutional case series and literature review
por: Tan, Hiang Jin, et al.
Publicado: (2023) -
Comparison of a histone deacetylase inhibitor plus exemestane with exemestane alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: A meta-analysis
por: Xu, Liang, et al.
Publicado: (2022) -
Encapsulated papillary carcinoma of the breast: A case report
por: Zhang, Joe, et al.
Publicado: (2023) -
A comparison of fulvestrant plus a targeted agent with fulvestrant alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: a meta-analysis
por: Xu, Liang, et al.
Publicado: (2018)